RNF13

Chr 3AD

ring finger protein 13

Also known as: DEE73, EIEE73, RZF

The protein encoded by this gene contains a RING zinc finger, a motif known to be involved in protein-protein interactions. The specific function of this gene has not yet been determined. Alternatively spliced transcript variants that encode the same protein have been reported. A pseudogene, which is also located on chromosome 3, has been defined for this gene. [provided by RefSeq, Jul 2008]

OMIMResearchGenerating clinical summary…
GOFmechanismADLOEUF 0.901 OMIM phenotype
Clinical SummaryRNF13
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
7 unique Pathogenic / Likely Pathogenic· 145 VUS of 312 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
0.90LOEUF
pLI 0.000
Z-score 1.86
OE 0.50 (0.290.90)
Tolerant

Typical tolerance to LoF variation

Missense Constraint?
0.90Z-score
OE missense 0.82 (0.720.93)
158 obs / 193.2 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.50 (0.290.90)
00.351.4
Missense OE?0.82 (0.720.93)
00.61.4
Synonymous OE?1.09
01.21.6
LoF obs/exp: 8 / 16.0Missense obs/exp: 158 / 193.2Syn Z: -0.62
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
strongRNF13-related congenital microcephaly, epileptic encephalopathy, blindness, and failure to thriveGOFAD

This gene — mechanism propensity

DN
0.6550th %ile
GOF
0.6932th %ile
LOF
0.2969th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median · 1 literature citation
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Literature Evidence

GOFHeterozygous RNF13 Gain-of-Function Variants Are Associated with Congenital Microcephaly, Epileptic Encephalopathy, Blindness, and Failure to Thrive.Edvardson S(1), Nicolae CM(2), Noh GJ(3), Burton JE(4), Punzi G(5), Shaag A(6), Bischetsrieder J(3), De Grassi A(5), Pierri CL(5), Elpeleg O(7), Moldov1

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

References

  1. 1.PMID 30595371

ClinVar Variant Classifications

312 submitted variants in ClinVar

Classification Summary

Pathogenic3
Likely Pathogenic4
VUS145
Likely Benign110
Benign21
Conflicting16
3
Pathogenic
4
Likely Pathogenic
145
VUS
110
Likely Benign
21
Benign
16
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
1
2
0
0
3
Likely Pathogenic
4
0
0
0
4
VUS
15
122
8
0
145
Likely Benign
1
16
35
58
110
Benign
1
14
5
1
21
Conflicting
16
Total221544859299

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

21 pathogenic / likely-pathogenic (of 21) ClinVar copy-number / structural variants overlap RNF13 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

RNF13 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →